K
Karla V. Ballman
Researcher at Cornell University
Publications - 390
Citations - 34158
Karla V. Ballman is an academic researcher from Cornell University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 78, co-authored 353 publications receiving 29127 citations. Previous affiliations of Karla V. Ballman include University of South Florida & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Ischemic stroke after heart failure: a community-based study.
Brandi J. Witt,Robert D. Brown,Steven J. Jacobsen,Susan A. Weston,Karla V. Ballman,Ryan A. Meverden,Véronique L. Roger +6 more
TL;DR: In the community, persons with HF have a large increase in the risk for ischemic stroke compared with the general population, which results in a >2-fold increase in mortality.
Journal ArticleDOI
Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial
TL;DR: The cumulative incidence of CE at 6 years was slightly higher with the addition of trastuzumab; however, the late development of CE is infrequent, and trastzumab (in the context of anthracycline- and taxane-based therapy) continues to have a favorable benefit-risk ratio.
Journal ArticleDOI
Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods
Evanthia Galanis,Jan C. Buckner,Matthew J. Maurer,Rene Sykora,René Castillo,Karla V. Ballman,Bradley J. Erickson +6 more
TL;DR: Time-dependent Cox models demonstrated that progression as determined by 1D, 2D, area, and volume measurements in gadolinium-enhanced images was predictive of survival of patients with enhancing tumors, although the small number of responders limits definitive conclusions.
Journal ArticleDOI
Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocol.
Mario Gaudino,John H. Alexander,Faisal G. Bakaeen,Karla V. Ballman,Fabio Barili,Antonio M. Calafiore,Piroze M. Davierwala,Steven Goldman,Peter Kappetein,Roberto Lorusso,Darren Mylotte,Domenico Pagano,Marc Ruel,Thomas A. Schwann,Hisayoshi Suma,David P. Taggart,Robert F. Tranbaugh,Stephen E. Fremes +17 more
TL;DR: The primary outcome of the ROMA trial will be a composite of death from any cause, any stroke, post-discharge myocardial infarction and/or repeat revascularization, and the secondary outcome will be all-cause mortality.
Journal ArticleDOI
NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases.
Paul D. Brown,Anthony L. Asher,Karla V. Ballman,Elana Farace,Jane H. Cerhan,S. Keith Anderson,Xiomara W. Carrero,Fred G. Barker,Richard L. Deming,Stuart H. Burri,Cynthia Ménard,Caroline Chung,Volker W. Stieber,Bruce E. Pollock,Evanthia Galanis,Jan C. Buckner,Kurt A. Jaeckle +16 more
TL;DR: Decline in cognitive function, specifically immediate recall, memory and verbal fluency, was more frequent with the addition of WBRT to SRS, and initial treatment with SRS and close monitoring is recommended to better preserve cognitive function in patients with newly diagnosed brain metastases that are amenable to S RS.